NEW DELHI (Reuters) -- India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-19 infections, leading to a crippling shortages in many parts.
Coronavirus
India bans anti-viral drug Remdesivir exports as coronavirus rages on
New COVID-19 cases surged to 152,879, the sixth record rise in seven days